Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study

Pierfrancesco Bassi

doi:10.1016/j.eururo.2013.08.018

Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study

Pierfrancesco Bassi

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo in rivista

40 Citazioni (Scopus)

Abstract

Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.

Lingua originale	English
pagine (da-a)	733-739
Numero di pagine	7
Rivista	EUROPEAN UROLOGY
Volume	65
DOI	https://doi.org/10.1016/j.eururo.2013.08.018
Stato di pubblicazione	Pubblicato - 2014

Keywords

Adolescent
Adult
Aged
Aged, 80 and over
Benzylamines
Cardiovascular events
Complementary Therapies
Dapoxetine
Humans
Male
Middle Aged
Naphthalenes
Premature Ejaculation
Prospective Studies
Safety
Serotonin Uptake Inhibitors
Syncope
Young Adult

Accesso al documento

10.1016/j.eururo.2013.08.018

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{3e9e51ea647f4472a0a26cdaf04814fc,

title = "Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study",

abstract = "Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.",

keywords = "Adolescent, Adult, Aged, Aged, 80 and over, Benzylamines, Cardiovascular events, Complementary Therapies, Dapoxetine, Humans, Male, Middle Aged, Naphthalenes, Premature Ejaculation, Prospective Studies, Safety, Serotonin Uptake Inhibitors, Syncope, Young Adult, Adolescent, Adult, Aged, Aged, 80 and over, Benzylamines, Cardiovascular events, Complementary Therapies, Dapoxetine, Humans, Male, Middle Aged, Naphthalenes, Premature Ejaculation, Prospective Studies, Safety, Serotonin Uptake Inhibitors, Syncope, Young Adult",

author = "Pierfrancesco Bassi",

year = "2014",

doi = "10.1016/j.eururo.2013.08.018",

language = "English",

volume = "65",

pages = "733--739",

journal = "EUROPEAN UROLOGY",

issn = "1828-6569",

publisher = "Milano: Elsevier Italia",

}

TY - JOUR

T1 - Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study

AU - Bassi, Pierfrancesco

PY - 2014

Y1 - 2014

N2 - Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.

AB - Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Benzylamines

KW - Cardiovascular events

KW - Complementary Therapies

KW - Dapoxetine

KW - Humans

KW - Male

KW - Middle Aged

KW - Naphthalenes

KW - Premature Ejaculation

KW - Prospective Studies

KW - Safety

KW - Serotonin Uptake Inhibitors

KW - Syncope

KW - Young Adult

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Benzylamines

KW - Cardiovascular events

KW - Complementary Therapies

KW - Dapoxetine

KW - Humans

KW - Male

KW - Middle Aged

KW - Naphthalenes

KW - Premature Ejaculation

KW - Prospective Studies

KW - Safety

KW - Serotonin Uptake Inhibitors

KW - Syncope

KW - Young Adult

UR - http://hdl.handle.net/10807/62780

U2 - 10.1016/j.eururo.2013.08.018

DO - 10.1016/j.eururo.2013.08.018

M3 - Article

SN - 1828-6569

VL - 65

SP - 733

EP - 739

JO - EUROPEAN UROLOGY

JF - EUROPEAN UROLOGY

ER -

Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo